Stocksigma LogoStocksigma Logo

Kilitch Drugs Shareholders Approve Material Subsidiary Stake Sale and Debt Conversion

Kilitch Drugs (India) Ltd announced the approval of all four resolutions at its EGM held on 16th Nov'26 with requisite majorities

Kilitch Drugs Shareholders Approve Material Subsidiary Stake Sale and Debt Conversion

Kilitch Drugs India Ltd 路 Extra Ordinary General Meeting 路 16 Nov 2026, 9:17 pm

Kilitch Drugs Shareholders Approve Material Subsidiary Stake Sale and Debt Conversion Kilitch Drugs (India) Ltd announced the approval of all four resolutions at its EGM held on 16th Nov'26 with requisite majorities. Shareholders unanimously passed a special resolution to sell the company's entire shareholding in its material subsidiary and an ordinary resolution to convert existing debt extended to the subsidiary into equity shares. Additionally, shareholders approved the appointments of Dr. Milind Kishor Madhani and Mr. Gautam Rajan as Non-Executive Independent Directors for five consecutive years each, with over 99.99% voting in favour. Total voter turnout stood at 73.02%.

Original exchange filing (PDF)

More announcements from Kilitch Drugs India Ltd

All Kilitch Drugs India Ltd announcements